Cyndeo Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$631K Sell
1,742
-18
-1% -$6.16K 0.03% 318
2026
Q1
$619K Sell
1,760
-24,041
-93% -$8.57M 0.03% 292
2025
Q4
$8.44M Buy
25,801
+1,007
+4% +$319K 0.46% 62
2025
Q3
$7M Sell
24,794
-160
-0.6% -$46.4K 0.39% 73
2025
Q2
$6.97M Buy
24,954
+2,343
+10% +$664K 0.41% 72
2025
Q1
$7.04M Buy
22,611
+20,469
+956% +$6.04M 0.46% 72
2024
Q4
$558K Buy
2,142
+55
+3% +$16.3K 0.04% 279
2024
Q3
$673K Buy
2,087
+162
+8% +$53K 0.05% 259
2024
Q2
$601K Buy
1,925
+503
+35% +$148K 0.05% 259
2024
Q1
$404K Sell
1,422
-1,249
-47% -$365K 0.03% 284
2023
Q4
$769K Sell
2,671
-58
-2% -$15.8K 0.07% 211
2023
Q3
$734K Sell
2,729
-4,605
-63% -$1.15M 0.08% 193
2023
Q2
$1.63M Buy
+7,334
New +$1.7M 0.17% 140
2023
Q1
Sell
-847
Closed -$223K 322
2022
Q4
$223K Buy
+847
New +$227K 0.03% 288

Other funds holding AMGN

Cyndeo Wealth Partners's AMGN Position: Q2 2026 in Review

Cyndeo Wealth Partners reduced its Amgen (AMGN) stake by 1% in Q2 2026, selling an estimated $6.16K and leaving 1,742 shares worth $631K. The position accounts for 0.03% of the portfolio, ranked #318.

Cyndeo Wealth Partners first reported a position in AMGN in Q4 2022 and has held it in 14 quarters since. The position peaked at $8.44M in Q4 2025. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cyndeo Wealth Partners held 1,742 shares of Amgen worth $631K as of Q2 2026.
  • Cyndeo Wealth Partners sold 18 Amgen shares in Q2 2026, an estimated $6.16K.
  • Amgen made up 0.03% of Cyndeo Wealth Partners's portfolio in Q2 2026, its #318 holding.
  • Cyndeo Wealth Partners first reported a position in Amgen in Q4 2022 and has held it in 14 quarters since.
  • Cyndeo Wealth Partners's Amgen position peaked at $8.44M in Q4 2025.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cyndeo Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.